Videos
Mechanistic Approach Behind AMX0035 in Progressive Supranuclear Palsy: Gunter Hoglinger, MD
September 29th 2023The professor of neurology and translational neuroscientist at Ludwig-Maximillian’s University Munich detailed the logic behind the ORION study, a new trial assessing AMX0035, an approved therapy for ALS, in patients with progressive supranuclear palsy. [WATCH TIME: 4 minutes]
Adjusting Motor Fluctuation Management in an Era of Neuromodulation: Laxman Bahroo, DO
September 28th 2023The professor of neurology and resident program director at MedStar Georgetown University Hospital discussed how Parkinson disease motor fluctuations are managed amid new, novel technologies incorporated in the field. [WATCH TIME: 4 minutes]
Empowering Women to Develop Leadership Skills in Neurology: Lara V. Marcuse, MD
September 28th 2023The codirector of the Mount Sinai Epilepsy Program at the Icahn School of Medicine at Mount Sinai talked about the Women in Neurology and Leadership session she spoke in at IFN 2023. [WATCH TIME: 3 minutes]
Perfecting a Cocktail of Approaches to Treat Alzheimer Disease: Richard Isaacson, MD
September 27th 2023The director of the Center for Brain Health and Alzheimer Prevention Clinic at Florida Atlantic University provided perspectives on the multimodal, multitargeted approach needed to treat Alzheimer disease. [WATCH TIME: 5 minutes]
Advancements in Stroke Care, Ischemic Stroke, and Cerebral Hemorrhages: Matthew Schrag, MD, PhD
September 26th 2023The associate professor of neurology at Vanderbilt University Medical Center discussed the progress in stroke care, focusing on ischemic strokes and cerebral hemorrhages, and their connection with vascular diseases and cognitive disorders. [WATCH TIME: 3 minutes]
The Complex Landscape of NMOSD and MOGAD-Associated Diseases: Erin Longbrake, MD, PhD
September 26th 2023The associate professor of neurology at Yale School of Medicine discussed the differentiation of neuromyelitis optica spectrum disorders and myelin oligodendrocyte glycoprotein -associated disease from multiple sclerosis at IFN 2023. [WATCH TIME: 5 minutes]
Promise in PACAP Pathway for Treating Migraine: Jessica Ailani, MD
September 25th 2023The director of the MedStar Georgetown Headache Center provided insight on the excitement behind PACAP, how it may offer an alternate way of treating migraine, and where research behind it currently stands. [WATCH TIME: 4 minutes]
The Future of Parkinson Disease Treatment With Innovative Wearable Devices: Alistair Mackett, MD
September 24th 2023The movement disorder specialist at Cambridge University Hospitals NHS Foundation Trust discussed the rise of wearable technology for managing Parkinson disease to potentially empower patients and monitor the disease at early stages. [WATCH TIME: 4 minutes]
Importance of Identifying Etiology in Pediatric Stroke: Kristin Guilliams, MD, MSCI
September 21st 2023The associate professor at Washington University School of Medicine provided commentary on the state of care for pediatric stroke, and the challenges with identifying the most likely etiology. [WATCH 3 minutes]
Shift in Treatment Paradigm for Dravet Syndrome: Joseph Sullivan, MD
September 21st 2023The director of the Pediatric Epilepsy Center at UCSF provided perspective on the advances in the treatment of Dravet syndrome, emerging research concepts in the field, and the influence of genetic testing. [WATCH TIME: 5 minutes]
Leading Efforts in Advancing Neurodevelopmental Disorder Research: Walter E. Kaufmann, MD
September 20th 2023The adjunct professor of human genetics at Emory University School of Medicine talked about efforts from various communities in neurological disorders, such as Rett syndrome, to develop new measures for research. [WATCH TIME: 3 minutes]
Introduction of Antisense Oligonucleotides to Treat Genetic Forms of Epilepsy: Joseph Sullivan, MD
September 18th 2023The director of the Pediatric Epilepsy Center at UCSF discussed STK-001, an antisense oligonucleotide in development for Dravet syndrome, and the promise behind this type of targeted approach. [WATCH TIME: 4 minutes]
